Skip to main content
Clinical Trials/IRCT2016052111020N5
IRCT2016052111020N5
Completed
Phase 3

Assessment of the magnesium sulfate effect on the frequency of epilepsy and cesarean section in women with pre- eclampsia

Vice chancellor of Zahedan University of Medical Sciences0 sites500 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Vice chancellor of Zahedan University of Medical Sciences
Enrollment
500
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Vice chancellor of Zahedan University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • mild pre\- eclampsia; blood pressure between 130\-90/ 150\-105 mmhg/ mild protein urea
  • Exclusion criteria: sever pre\- eclampsia; blurred vision; sever protein urea; oligurea; impaired liver enzyme; previous cesarean

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials